0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Mouse MAb Antibody > NME1 / NDKA Antibody ( FITC )

NME1 / NDKA Antibody ( FITC ) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
11615-MM01-F
  YES          

NME1 / NDKA Antibody Datasheet

  Order or Inquire for NME1 / NDKA Antibody product Quality antibodies Antibody production services
 

NME1 / NDKA Antibody Product Information

Immunogen :

Recombinant Human NME1 / NDKA protein (Catalog#11615-H07E)

Reagents : FITC-conjugated mouse monoclonal antibody

Clone ID :

01

Ig Type :

Mouse IgG1

Concentration :

10 μl/Test, 0.1 mg/ml

Formulation : Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Preparation :

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human NME1 / NDKA (rh NME1 / NDKA; Catalog#11615-H07E; NP_000260.1; Ala 2-Glu 152) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.

NME1 / NDKA Antibody Usage Guide

Specificity :

Human NME1 / NDKA

Flow Cytometry :
NME1 / NDKA Flow Cytometry

Flow cytometric analysis of Human NME1 expression in HeLa cells. The cells were treated according to manufacturer's manual (BD Pharmingen™ Cat. No. 554714), and then stained with FITC Mouse anti-NME1 (11615-MM01-F). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.

Flow cytometry was performed on a BD FACSCalibur flow cytometry system

Please refer to www.sinobiological.com/Flow-Cytometry-FACS-Protocols-a-750.html for technical protocols.

Storage : This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !
Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

NME1 / NDKA Antibody Related Products & Topics

NME1 / NDKA Antibody Related Areas:

Enzyme>>Protein Kinase>>Intracellular Kinase>>NME1/NDKA

Signal Transduction>>Protein Kinase>>Intracellular Kinase>>NME1/NDKA

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
NME1/NDKA Human NME1/NDKA Protein, Recombinant 11615-H07E

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human
NME1/NDKA
WB, ELISA NME1/NDKA Antibody, Rabbit PAb 11615-RP01
Human
NME1/NDKA
WB, ELISA NME1/NDKA Antibody, Rabbit PAb (Antigen Affinity Purified) 11615-RP02
Human
NME1/NDKA
FCM NME1 / NDKA Antibody ( FITC ) 11615-MM01-F

NME1 / NDKA Antibody Background

Nucleoside diphosphate kinase A, also known as NDP kinase A, Tumor metastatic process-associated protein, Metastasis inhibition factor nm23, Granzyme A-activated Dnase, GAAD, NME1 and NDPKA, is a cytoplasm protein which belongs to the NDK family. Isoform 1 of NME1 is expressed in heart, brain, placenta, lung, liver, skeletal muscle, pancreas, spleen and thymus. Expressed in lung carcinoma cell lines but not in normal lung tissues. Isoform 2 NME1 is ubiquitously expressed and its expression is also related to tumor differentiation. Isoform 3 NME1 is ubiquitously expressed. NME1 / NDPKA is found in reduced amount in some tumor cells of high metastatic potential. However, increased NME1 levels correlate with aggressive tumor features in neuroblastoma. NME1 / NDPKA may have distinct if not opposite roles in different tumors. NME1 / NDPKA possesses nucleoside-diphosphate kinase, serine / threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. It is involved in cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor endocytosis, and gene expression. NME1 / NDPKA is required for neural development including neural patterning and cell fate determination.

References

  1. Hailat N. et al., 1991, J. Clin. Invest. 88:341-5.
  2. MacDonald N.J. et al., 1996, J. Biol. Chem. 271: 25107-16.
  3. Fan Z. et al., 2003, Cell 112: 659-72.
  4. Dephoure N. et al., 2008, Proc. Natl. Acad. Sci. USA. 105:10762-7.
  5. Choudhary C. et al., 2009, Science. 325: 834-40.
 

 

Primary Antibody Products